Category: Federal Circuit
-
Federal Circuit affirms district judge’s overruling of $469M jury verdict against DISH Network
ClearPlay sued DISH Network over its TV ad-skipping feature back in 2014, alleging infringement of two patents.
-
Federal Circuit says owners of patents subject to exclusive license still have standing to sue where terms don’t render rights “illusory”
A.L.M. and Ergon granted wide-ranging rights to an exclusive licensee – but retained the right to sue third-party infringers.
-
Federal Circuit reverses fee award and sanctions based on broad scope of what is purely lack of merit
The Federal Circuit affirmed dismissal of mCom’s banking patent suits and upheld invalidity findings against the remaining asserted claims, but reversed both the fee award and the sanctions imposed against counsel, reiterating that unsuccessful patent litigation alone does not establish exceptional or abusive conduct.
-
Actelion falls foul of disclosure-dedication rule, prosecution estoppel in Federal Circuit challenge to Mylan’s hypertension generic
The Federal Circuit agreed that there was neither literal infringement, nor infringement under the doctrine of equivalents.
-
Federal Circuit supports USITC fact-finding in import dispute over redesigned wet-dry vacuum cleaners
Tineco’s design-arounds have worked, but the Hong Kong company was unable to challenge the ITC’s domestic industry determination as to patentee Bissell.
-
“About this much”, is how much? Federal Circuit affirms poultry-processing patent invalidity over “vague, indefinite” pH claims
The decision underlines the need for appropriate precision and detail in patent claims that are quantitative in nature.
-
FedEx can fight another day in Qualcomm dispute, as Federal Circuit considers IPR real-parties-in-interest
The USPTO withdrew its initial defense of the PTAB’s refusal of FedEx’s arguments around real parties in interest.
-
LG TV case: Federal Circuit OKs mix of standard-related and standard-unrelated infringement theories for same patent claims
“Mixed” patent claims will be at issue sooner or later outside of the U.S., too.
-
Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drug
A $177M jury verdict, potentially tripled for willfulness, has been reinstated, and the standards for written description and enablement for genus-related patents have been clarified.
-
Federal Circuit throws VLSI a lifeline in multibillion-dollar Intel dispute, but it’ll all hinge on what happens in the Western District of Texas
VLSI now has several chances to revive its infringement claims against Intel, which will likely seek to delay further progress as it awaits a decision on its license defense.